RxDoctor Payments Data

Joseph Brito, MD

Urology · New Haven, CTNPI 1568722551

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Intuitive Surgical at 55.8% of the total. 2025 is the largest year on record at $2,706, more than ten times the $40 reported in 2019.

$3,695in general payments, 2019–2025

Across 24 payments — averaging $153.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Urogen Pharma, Inc.$883
  • Palette Life Sciences, Inc.$201
  • Profound Medical Corp.$154
  • Teleflex LLC$149
  • Telix Pharmaceuticals$144
  • plus $102 from 2 others

What the payments were for

  • Travel & lodging$1,12230%
  • Food & beverage$1,82349%
  • Education$75020%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,695 in reported general payments places this provider in the 60th percentile of 156 urology providers in Connecticut.

See all urology providers in Connecticut

Medicare billing

Part B allowed, 2024
$158,020
Medicare patients
484
Services billed
1,380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron107$80,486
Mirabegron ErMirabegron11$7,765
Tadalafil49$5,447
Tamsulosin Hcl405$4,999
Potassium Citrate ErPotassium Citrate30$4,601
Methenamine Hippurate52$4,110
Trospium Chloride ErTrospium Chloride24$3,505
Finasteride259$3,097
Alfuzosin Hcl ErAlfuzosin Hcl97$2,798
Trospium Chloride20$926
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip27$536
Cephalexin50$519
Dutasteride15$441
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst25$339
Estradiol15$283

Paid to pharmacies, not to this prescriber.

Other urology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →